Vicky B. Gregg
Director · QUEST DIAGNOSTICS INC
- 2024
- Jul 27, 2026
- 11
Summary
Latest filing:
Vicky B. Gregg is Director of QUEST DIAGNOSTICS INC (DGX). 11 SEC Form 4 filings on record going back to 2024, most recently on 27 July 2026. Most recent open-market trade: sold $240K of DGX on 28 November 2025. Lifetime open-market sales: $240K.
Recent transactions
11The latest 11 SEC Form 4 transactions reported by Vicky B. Gregg.
Trading pattern
InsiderAlpha's records for Vicky B. Gregg go back to 2024: 11 primary Form 4 filings, an average of 3.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vicky B. Gregg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- J. E. Davis - $17.08M in DGX purchases and sales in the last 12 months
- Catherine T. Doherty - $6.96M in DGX purchases and sales in the last 12 months
- Michael E. Prevoznik - $6.65M in DGX purchases and sales in the last 12 months
- Karthik Kuppusamy - $2.17M in DGX purchases and sales in the last 12 months
- Patrick Plewman - $2.03M in DGX purchases and sales in the last 12 months
- Mark E. Delaney - $1.86M in DGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vicky B. Gregg?
Vicky B. Gregg is a corporate insider, tracked as Director of QUEST DIAGNOSTICS INC (DGX). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vicky B. Gregg submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Vicky B. Gregg been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($240K) across all tracked filings.